Naloxone Affordability Act of 2023
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Naloxone Affordability Act of 2023
This bill requires the Government Accountability Office to study health insurance coverage and out-of-pocket costs for naloxone as an over-the-counter medication.
Naloxone is a medication that temporarily reverses opioid overdoses. Historically, naloxone required a prescription and so was typically covered by health insurance. However, the Food and Drug Administration approved a naloxone nasal spray (sold under the brand name Narcan) for use without a prescription on March 29, 2023, and health insurance does not generally cover over-the-counter medications.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 1373: Naloxone Affordability Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-S-1373/
"S. 1373: Naloxone Affordability Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-1373/.
S. 1373, 118th Cong. (2026), https://openamerica.io/bill/118-S-1373/.
[S. 1373: Naloxone Affordability Act of 2023](https://openamerica.io/bill/118-S-1373/)